| |  | | | | By Katie Palmer Molly Ferguson for STAT Google Translate has become a ubiquitous — and largely under-examined — part of patient care. Researchers are trying to change that. Read More | | By Lev Facher Anna Moneymaker/Getty Images Congress funded ARPA-H, the agency Biden pledged will help “end cancer as we know it," but left major questions unanswered. Read More | | By Matthew Herper National Institute on Aging, NIH When it comes to Biogen’s controversial Alzheimer’s drug Aduhelm, even publishing the data is steeped in drama. Read More | | Sponsor content by STAT Events Battle scars: The journey from lab to patient's bedside Join STAT on May 3 in Boston to explore the challenges, and the unique opportunities for new approaches, solutions, and partnerships, of the drug development process. This in-person program will bring together a diverse group of individuals to share their perspectives about the drug development process. Stay once the conversation is complete for a networking and cocktail reception with STAT and your fellow attendees. Get your ticket now (and save 40% as a STAT+ subscriber). | | By Jonathan Wosen Yohei Shibuya, Stanford University School of Medicine The study's authors and observers say it's the first-ever study to report that microglia replacement can help treat a disease. Read More | | By Ed Silverman APStock A group of Congressional lawmakers is accusing PhRMA of providing “misleading information” in response to its questions on drug pricing. Read More | | By Patrick Skerrett This week on "The First Opinion Podcast," diabetes advocate Alina Bills talks about insulin's high cost and social media efforts to help. Read More | | By Emma Biegacki YUKI IWAMURA/AFP via Getty Images Emergency response programs often fail to consider the needs of people with opioid and other substance use disorders. Read More | |
No comments